Add BrightSurf on Google Email

Visual tests could indicate cognitive decline – study

A new study from Anglia Ruskin University suggests that reaction times could be an early indicator of cognitive decline and dementia risk. Researchers found that people screening positive for mild cognitive impairment performed significantly worse on visual tasks, taking longer to respond than cognitively healthy adults. This could lea...

SourceAnglia Ruskin University·JournalBrain Sciences·TypeExperimental study·DateNov 11, 2026

KAIST, new discovery in suppressing toxic aggregation of a dementia-related protein opens a potential therapeutic avenue

A KAIST-led research team found a protein-regulatory function of zinc finger proteins that suppresses harmful amyloid-beta aggregation, reducing toxicity and improving recognition memory in a mouse model of Alzheimer's disease. The approach also breaks down preformed fibrils into less toxic fragments.

Good sleep linked to better brain health in cardiometabolic disease

Research from Karolinska Institutet found that people with type 2 diabetes, heart disease, or stroke who sleep well perform better on cognitive tests and have larger brain volumes than those who sleep poorly. This study suggests that healthy sleep may help mitigate the negative effects of cardiometabolic disease on brain health.

SourceKarolinska Institutet·JournalJournal of the American Heart Association·TypeObservational study·DateNov 4, 2026

More education reduces dementia risk decades later

Researchers found that the 1972 British compulsory-schooling reform increased the minimum school-leaving age from 15 to 16 reduced diagnoses of Alzheimer's disease and related dementias decades later. Additionally, the study uncovered that education may be particularly protective for those at greatest inherited risk, challenging the id...

SourceUniversity of Southern California·JournalProceedings of the National Academy of Sciences·DateOct 26, 2026

Who gets Alzheimer’s drugs? Race, vulnerability and health status shape access

A new study found significant disparities in access to anti-amyloid Alzheimer's treatments, with Black adults and Hispanic adults having lower odds of receiving the medication. However, once treatment began, patients were equally likely to take the medication as prescribed, regardless of their race or ethnicity.

SourceMichigan Medicine - University of Michigan·JournalNeurology·TypeObservational study·DateOct 15, 2026

Frequent and unintentional daytime napping linked to higher dementia risk in older adults

A study of nearly 1,000 older Americans found that frequent and unintentional daytime napping are linked to a higher risk of developing dementia. Napping habits, not just nighttime sleep, may signal or contribute to dementia risk. The study suggests that monitoring napping behaviors could serve as an early and accessible marker to help...

Study offers new clues about how genetic risk for Alzheimer’s affects brain immune cells

A study by CU Anschutz researchers has found a possible link between the APOE4 gene, fat in the brain, and inflammation, which may help explain how genetic risk factors for Alzheimer's disease affect the brain. The study suggests that the ApoE protein can change how brain immune cells handle fat and trigger inflammation.

SourceUniversity of Colorado Anschutz·JournalAlzheimer’s & Dementia·DateOct 12, 2026

Large global study examines Alzheimer’s blood biomarker across racial and ethnic groups

A large global study of 15,612 adults found that blood biomarker levels varied across racial and ethnic groups, but the relationship between biomarker levels and brain amyloid was generally consistent. The study's findings support the use of blood-based biomarkers to screen for elevated brain amyloid in preclinical Alzheimer's disease ...

SourceKeck School of Medicine of USC·JournalJAMA Neurology·TypeData/statistical analysis·DateOct 12, 2026

Study finds dementia influences decisions about life-sustaining treatment, even when advance directives request it

A study by CU Anschutz researcher found that dementia influences decisions on life-sustaining treatment, even when advance directives request it. Participants were 19 percentage points less likely to recommend life-sustaining treatment for patients with dementia than for those without, even with documented wishes calling for it.

SourceUniversity of Colorado Anschutz·JournalJAMA Network Open·DateOct 7, 2026

Navigating tough conversations with people who have dementia to stop driving

Flinders University researchers have identified a need for structured communication by health professionals when addressing driving cessation with people with dementia. The study suggests four phases of support: prepare the person, navigate fitness-to-drive decisions, deliver a recommendation, and adjust to life without driving.

SourceFlinders University·JournalAustralasian Journal on Ageing·TypeObservational study·DateSep 30, 2026

USC develops algorithmic tool to improve screening of patients for Alzheimer's clinical trial

Researchers at USC developed an algorithmic tool to improve screening of patients for Alzheimer's clinical trials, reducing unnecessary PET scans by over half. The tool uses blood plasma biomarkers to identify patients at risk of Alzheimer's disease, enabling faster and more efficient recruitment for trials like AHEAD 3-45.

SourceKeck School of Medicine of USC·JournalAlzheimer’s & Dementia·TypeExperimental study·DateSep 9, 2026

Sharpening minds in the community: Attention emerges as a key responsive outcome in municipal dementia prevention

A community-adapted brain health program in Kikuyo Town, Japan, has achieved significant improvements in attention scores and dietary balance among older adults. The 24-week program, combining aerobic exercise, cognitive exercises, and lifestyle guidance, resulted in high attendance rates and positive feedback.

SourceKumamoto University·JournalArchives of Gerontology and Geriatrics·TypeObservational study·DateSep 3, 2026

HRT linked to lower dementia risk in large UK study

A large UK study found that hormone replacement therapy (HRT) may reduce the risk of dementia, particularly for women who have undergone surgical menopause. The study, which followed over 180,000 postmenopausal women, found that HRT was associated with a 16% lower risk of developing Alzheimer's disease compared to non-users.

SourceUniversity of East Anglia·JournalAlzheimer s & Dementia·TypeObservational study·DateAug 26, 2026